News | PET Imaging | June 25, 2018

Philips North America and GE Healthcare Win IMV PET Imaging ServiceTrak Awards

Philips awarded Best Service and GE awarded Best Customer Satisfaction

Philips North America and GE Healthcare Win IMV PET Imaging ServiceTrak Awards

June 25, 2018 — IMV, part of the Science and Medicine Group and a market research and business intelligence provider to the imaging industry, announced the category winners of the 2017-18 IMV ServiceTrak in PET Imaging. Philips North America was the winner in the Best Service category, while GE Healthcare came out on top in Best Customer Satisfaction.   

Positron emission tomography (PET) imaging is a highly sensitive form of molecular imaging (nuclear medicine) which uses radioactive pharmaceuticals to measure chemical changes occurring in the body before physical signs of disease can be detected. Because of the energy produced by the positron emission, PET is more sensitive than traditional nuclear medicine imaging. Most PET scanners are combined with computed tomography (CT) to receive PET and CT images at the same time, with the PET image showing metabolism and the function of cells and the CT image showing anatomical details. With a combination of these two scanning technologies, a PET-CT scan helps physicians to more accurately diagnose and localize cancer, brain disorders, and some heart disease.

In 2017, an estimated 1.9 million clinical PET scans were performed in over 2,400 locations using fixed PET scanners or mobile services. Over 90 percent of these scans were performed:

  • To detect cancer;
  • To determine if cancer has spread;
  • To access the effectiveness of a cancer treatment plan; or
  • To determine if a cancer has returned after treatment.

PET scanners are an essential tool in the early detection and treatment of cancer.

IMV produces an annual series of proprietary ServiceTrak Imaging reports derived from extensive phone interviews with imaging professionals in hospital departments and independent imaging centers in the U.S. Imaging professionals are asked to rate their level of satisfaction with the equipment manufacturers, system performance and the service received for their imaging equipment. Satisfaction ratings are collected on a 10-point scale, where 10 equals "excellent" and 1 equals "very poor". Report analysis is based on the percentage of highly satisfied (%HS) responses which are represented by satisfaction ratings of a 9 or 10 on this scale.

The ServiceTrak Imaging awards are presented to the manufacturer with the highest %HS in each of three categories, representing the Industry Best Of: Customer Satisfaction, System Performance and Service. The Best Of Customer Satisfaction award is given to the manufacturer who has the highest %HS responses when asked to rate the likelihood they will purchase again from their current manufacturer. The Best Of System Satisfaction award is given to the manufacturer whose customers have the highest %HS responses when asked to rate their overall system performance. The Best Of Service award is given to the manufacturer whose customers give the highest %HS responses when asked to rate overall OEM service performance.

The 2017-18 ServiceTrak PET awards are based on interviews conducted in 2017 with respondents in 275 unique imaging locations having 289 PET systems.

For more information: www.imvinfo.com

Related Content

SIR-Spheres Y-90 resin

SIR-Spheres Y-90 resin microspheres are released into the hepatic artery.

News | Nuclear Imaging | February 14, 2020
February 14, 2020 —  ...
Nuclear imaging equipment growth in 2020
News | Nuclear Imaging | February 14, 2020
February 14, 2020 — The nuclear imaging equipment
A 50-y-old postmenopausal woman with fibroadenoma (arrows) in left breast

A 50-y-old postmenopausal woman with fibroadenoma (arrows) in left breast. (A) Unenhanced fat-saturated T1-weighted MRI shows extreme amount of FGT (ACR d). (B) Moderate BPE is seen on dynamic contrast-enhanced MRI at 90 s. (C) Mean ADC of breast parenchyma of contralateral breast on diffusion-weighted imaging with ADC mapping is 1.5 × 10?3 mm2/s. (D) On 18F-FDG PET/CT, lesion is not 18F-FDG-avid, and BPU of normal breast parenchyma is relatively high, with SUVmax of 3.2. Photo courtesy of K Pinker, et al., Medical University of Vienna, Vienna, Austria

News | PET-MRI | January 27, 2020
January 27, 2020 — Researchers have identified several potentially useful...
Nuclear imaging of the spine shown on Philips Healthcare BrightView XCT

Image courtesy of Philips Healthcare

News | Nuclear Imaging | January 27, 2020
January 27, 2020 — According to the new market research report "...
Sponsored Content | Videos | Mammography | January 24, 2020
Imaging Technology News Contributing Editor Greg Freiherr interviewed...
This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.   #RSNA #

This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.

Feature | RSNA | January 20, 2020 | Dave Fornell, Editor
Here are images of some of the newest new medical imaging technologies displayed on the expo floor at the ...
Sponsored Content | Videos | Computed Tomography (CT) | January 03, 2020
In this Conversations video at AHRA, Ryan K.
Feinstein Institutes' Thomas Chaly, Ph.D., poses in front of a PET-CT imaging machine. He has been instrumental in pushing for FDA approval of a new PET imaging agent, Fluorodopa F-18 (FDOPA), to combat Parkinson’s

Feinstein Institutes' Thomas Chaly, Ph.D., in front of a PET-CT imaging machine. He has been instrumental in pushing for FDA approval of a new PET imaging agent, Fluorodopa F-18 (FDOPA), to combat Parkinson’s

News | Nuclear Imaging | December 26, 2019
December 26, 2019 — The Feinstein Institutes for Medical R...
Prof. Dr. Samer Ezziddin from Saarland University/Saarland University Hospital.

Prof. Dr. Samer Ezziddin from Saarland University/Saarland University Hospital. Photo courtesy of Thorsten Mohr/Saarland University

News | Prostate Cancer | November 28, 2019
November 28, 2019 — Reports of new cancer treatments